| Intrinsic Valuation of: CHKP | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 10 | Market Cap | $13B | |||||
| 2021 | - | - (-) | P/E Ratio | 13 | Total Asset | $8B | |||||
| 2022 | $1B | - (-) | Net Income | $1B | Total Debt | $2B | |||||
| 2023 | $1B | -5.3% (-8.6%) | EBITDA | $1B | Total Liab | $5B | |||||
| 2024 | $1B | 0.9% (-5.0%) | Opr Margin | 30.49 | Debt/Equity | 0.68 | |||||
| 2025 | $1B | 14.1% (7.4%) | PreTax Margin | 30.42 | BV/Share | 7 | |||||
| 5Y Average FCF | $1B | 4.5% (-2.1%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.5%) | ||||||||||
| 2026 | $1B | MBG Intrinsic Value | $87 | ||||||||
| 2027 | $1B | ||||||||||
| 2028 | $1B | ||||||||||
| 2029 | $1B | ||||||||||
| 2030 | $1B | ||||||||||
| 2031 | $1B | ||||||||||
| Terminal Value | $32B | Net Worth/Share | $28 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $27B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $2B | $262 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $2B | WACC | 6.5% | 246 | 268 | 295 | 329 | 376 | |||
| Equity Value | $27B | 7.1% | 218 | 235 | 255 | 280 | 312 | ||||
| Shares Outstanding | 104,027,807 | 7.8% | 196 | 209 | 224 | 243 | 266 | ||||
| 8.4% | 178 | 188 | 200 | 214 | 231 | ||||||
| DCF Intrinsic Value | $262 | 9.0% | 163 | 171 | 181 | 192 | 205 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||